Fig. 5From: Renal protection CT protocol using low-dose and low-concentration iodine contrast medium in at-risk patients of HCC and with chronic kidney disease: a randomized controlled non-inferiority trialA 68-year-old man with liver cirrhosis in the RPP group. The amount of iodine administered was 301.5Â mg/kg. Compared to the iDose image (a, b), both the 50-keV (c, d) and DL-based iodine-boosting reconstruction (e, f) demonstrated significantly increased contrast between the hepatic vessels (arrowheads) and enhanced main portal vein visualization (asterisk)Back to article page